ArticleThe oncologist2024

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.